Clinical trials
Pancreatic Neoplasms trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2008 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 5 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Withdrawn | 1 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese University of Hong Kong | 9 |
| Hoffmann-La Roche | 3 |
| The University of Hong Kong | 3 |
| Bristol-Myers Squibb | 2 |
| Novartis Pharmaceuticals | 2 |
| Amgen | 1 |
| Arbele Pty Ltd | 1 |
| Boston Scientific Corporation | 1 |
| Celgene | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 29 |
| Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Cholangiocarcinoma | 3 |
| Colorectal Neoplasms | 3 |
| Melanoma | 3 |
| Brain Neoplasms | 2 |
| Cancer Pain | 2 |
| Endocrine Gland Neoplasms | 2 |
Trials
Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.